Log In
Print
BCIQ
Print
Print this Print this
 

MEDI0680 (formerly AMP-514)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
Description mAb against programmed cell death 1 (PDCD1; PD-1; CD279)
Molecular Target Programmed cell death 1 (PD-1) (PDCD1) (CD279)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today